Interplay of gut microbiota, glucagon-like peptide receptor agonists, and nutrition: new frontiers in metabolic dysfunction-associated steatotic liver disease therapy
Ruban A, Doshi A, Lam E, Teare JP
Firstly, it will allow innovators to play across several market segments, for example, seamlessly addressing evolving needs along the patient journey as patients transition from induction to maintenance phase, by owning a high potency injectable and an oral therapy
We're not so good at coaching
Our experienced medical team works closely with each patient to develop a complete treatment plan that includes prescribed GLP-1 medication, personalized nutrition guidance, and tailored exercise recommendations